Task: Answer the multiple-choice question.
Query: Which drug exhibits a 14.727\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1cc(C)nc(SCc2cc(=O)c(OC(=O)c3ccc(S(=O)(=O)N(C)C)cc3)co2)n1
b. CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
c. c1ccc(-c2nn3nnnc3c3ccccc23)cc1
Answer: b. CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
N-[1-(4-propyl-5-sulfanylidene-1H-1,2,4-triazol-3-yl)ethyl]benzamide